CNTA logo

Centessa Pharmaceuticals (CNTA) return on equity

annual ROE:

-58.71%-5.92%(-11.21%)
December 31, 2024

Summary

  • As of today (July 1, 2025), CNTA annual return on equity is -58.71%, with the most recent change of -5.92% (-11.21%) on December 31, 2024.
  • CNTA annual ROE is now -223.47% below its all-time high of 47.55%, reached on December 31, 2020.

Performance

CNTA ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCNTAprofitability metrics

quarterly ROE:

-62.56%+9.36%(+13.01%)
March 31, 2025

Summary

  • As of today (July 1, 2025), CNTA quarterly return on equity is -62.56%, with the most recent change of +9.36% (+13.01%) on March 31, 2025.
  • Over the past year, CNTA quarterly ROE has dropped by -6.49% (-11.57%).
  • CNTA quarterly ROE is now -8024.68% below its all-time high of -0.77%, reached on March 31, 2021.

Performance

CNTA quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCNTAprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

CNTA ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-11.2%-11.6%
3 y3 years--142.1%
5 y5 years--

CNTA ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-11.2%+8.7%-90.6%+13.0%
5 y5-year-223.5%+8.7%-8024.7%+13.0%
alltimeall time-223.5%+8.7%-8024.7%+13.0%

CNTA ROE History

DateAnnualQuarterly
Mar 2025
-
-62.56%(-13.0%)
Dec 2024
-58.71%(+11.2%)
-71.92%(+33.5%)
Sep 2024
-
-53.87%(-14.6%)
Jun 2024
-
-63.08%(+12.5%)
Mar 2024
-
-56.07%(-1.1%)
Dec 2023
-52.79%(-17.9%)
-56.72%(+5.0%)
Sep 2023
-
-54.03%(+0.1%)
Jun 2023
-
-54.00%(-9.6%)
Mar 2023
-
-59.74%(+11.2%)
DateAnnualQuarterly
Dec 2022
-64.31%(-235.2%)
-53.74%(+37.0%)
Sep 2022
-
-39.22%(+19.5%)
Jun 2022
-
-32.83%(+27.1%)
Mar 2022
-
-25.84%(+37.9%)
Dec 2021
-
-18.74%(-13.1%)
Sep 2021
-
-21.56%(+113.7%)
Jun 2021
-
-10.09%(+1210.4%)
Mar 2021
-
-0.77%
Dec 2020
47.55%
-

FAQ

  • What is Centessa Pharmaceuticals annual return on equity?
  • What is the all time high annual ROE for Centessa Pharmaceuticals?
  • What is Centessa Pharmaceuticals annual ROE year-on-year change?
  • What is Centessa Pharmaceuticals quarterly return on equity?
  • What is the all time high quarterly ROE for Centessa Pharmaceuticals?
  • What is Centessa Pharmaceuticals quarterly ROE year-on-year change?

What is Centessa Pharmaceuticals annual return on equity?

The current annual ROE of CNTA is -58.71%

What is the all time high annual ROE for Centessa Pharmaceuticals?

Centessa Pharmaceuticals all-time high annual return on equity is 47.55%

What is Centessa Pharmaceuticals annual ROE year-on-year change?

Over the past year, CNTA annual return on equity has changed by -5.92% (-11.21%)

What is Centessa Pharmaceuticals quarterly return on equity?

The current quarterly ROE of CNTA is -62.56%

What is the all time high quarterly ROE for Centessa Pharmaceuticals?

Centessa Pharmaceuticals all-time high quarterly return on equity is -0.77%

What is Centessa Pharmaceuticals quarterly ROE year-on-year change?

Over the past year, CNTA quarterly return on equity has changed by -6.49% (-11.57%)
On this page